Skip to main content
. 2021 May 17;13(2):47–65. doi: 10.1007/s40506-021-00248-7

Table 1.

Vaccine recommendations for CKD and KT patients [112]

Vaccine Type Safe pre-transplant1 Safe post-transplant Clinical response monitoring
Influenzaa I (intradermal) Yes Yes No
Influenza LAIV (intranasal) Yes No No
Hepatitis Bb I Yes Yes Yes
Hepatitis A I Yes Yes Yes
Tetanus/diphtheria I Yes Yes No
Pertussis I Yes Yes No
Measles, mumps, rubella LAIV Yes No Yes
Varicella LAIV Yes No Yes

Zoster

(Zostavax)c

LAIV Yes No No

Zoster

(Shingrix)c

I Yes -- No

Pneumococcal

(PCV13)

I Yes Yes No

Pneumococcal

(PPSV23)

I Yes Yes No
Meningococcus I Yes Yes No
Human papillomavirus virus I Yes Yes No

Poliod

(IPV)

I Yes Yes No
Haemophilus influenza I Yes Yes No
Rabies I Yes Yes Yes

Typhoid

ViCPS (Typhim Vi, Sanofi Pasteur)

I

(intradermal)

Yes Yes No

Typhoid

Ty21a (Vivotif, Swiss PaxVax)

LAIV

(oral)

Yes No No
Cholera LAIV Yes No No
Japanese encephalitis I Yes Yes No
Yellow fever LAIV Yes No No

I, inactivated vaccine; LAIV, live attenuated vaccine

1When indicated vaccination series are preferred to be completed prior to transplantation to increase efficacy

aInfluenza higher dose influenza vaccination should be considered for transplant recipients

bHepatitis B vaccine both HD patients and KT patients should receive the higher dose vaccine at 40 mcg of HBV surface antigen for Recombivax HB or Engerix-B

cShingrix is the preferred Zoster vaccine per ACIP recommendation

dPolio IPV only polio vaccine licensed for adults available in the USA